StockGuru Welcomes
Lotus Pharmaceuticals, Inc.Lotus Pharmaceuticals, Inc.
(OTCBB: LTUS)
Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) is an emerging Chinese leader in offering medicines to ensure well-being, cure disease and improve quality of life. The company’s goal is to discover, develop and successfully market innovative products to help people globally, to help patients manage afflictions and to enhance the quality of life.
Lotus continues to discover, develop and successfully market innovative products to help people globally, to help patients manage afflictions and to enhance the quality of life. Lotus has a unique positioning amongst major pharmaceutical companies in China, as it resides in a small class of leadership in both patented and generic pharmaceuticals. The Company is strengthening its medicine-based portfolio, and investing in strategic growth platforms as follows:
* Innovation-driven prescription medicines
* Cost-effective and high-quality generic medicines
* Retail Sales of leading self-medication (OTC) brands
* Human vaccines that address public health and therapeutic needs
Lotus leads their regional industry with 14 new product approvals in the China since 2000, with key approvals in 2005 for Levofloxacin Lactate Freeze-Dry Powder Injection (Junxin), the broad spectrum antibiotic. Lotus intends to make VALSARTAN, one of their best selling products, the number one prescribed brand in its class of high blood pressure medications in China. Lotus owns and operates 10 retail outlets throughout metropolitan Beijing.
Lotus has a unique positioning amongst major pharmaceutical companies in China, as it resides in a small class of leadership in both patented and generic pharmaceuticals. The company is strengthening its medicine-based portfolio, investing in strategic growth platforms:
* Innovation-driven prescription medicines
* Cost-effective and high-quality generic medicines
* Retail Sales of leading self-medication (OTC) brands
* Human vaccines that address public health and therapeutic needs
Retail Pharmacies
The company owns and operates 10 drug stores throughout many different districts of Beijing, including:
* Xin Zhong Tai Drugstore
* Long Ren Tang Drugstore
* Wan Shou Road Drugstore
* He Ping Li Drugstore
* Feng Lin Lu Zhou
* Youth Lake Drugstore
* Capital Airport Drugstore
* Young An Zhong Sheng Drugstore
* Cheng Zhuang Road Drugstore
* Feng Tai Drugstore
These 10 drugstores all deal in Western and traditional Chinese drinking pieces, medical treatment facilities of over 5,000 types, and adopts the general principles of the unification of distribution, balance, price and the comprehensive management. In face of the fierce competition of the market, with the faith in industry, practice, stridence and progress, Lotus has set up a development mode that agrees with the exploding Chinese economy and fits its own advancement.
Lotus intends to adhere to the general development strategy of putting pharmaceutical production and trade as its priority; adopt the principle of specification and scale-managements. In the future, the company plans to still concentrate on the development of high-tech personnel, knowledge, and scientific research, giving priority to projecting the image of the Company, and progress in the direction of industrialization and globalization of pharmacy.
Continued Growth
Pharmaceuticals continue to be the largest and most profitable business for Lotus. Cardiovascular and Oncology franchises are the key growth drivers, delivering dynamic performances in challenging markets, particularly from VALSARTAN for hypertension.
Altogether there are four organs attached to this Corporation handling respectively the scientific research on new medicine, the production, wholesale and retail of medicine to treat chronic myeloid leukemia. Overall, the division once again successfully increased its market share last year. With a total of 12 projects in clinical development, Lotus has a full, innovative and promising pipeline. The Company will continue to underwrite research and development in order to keep a sharp eye on the market’s evolution.
On February 15, 2007, Lotus Pharmaceuticals, Inc. announced it had completed a $3 million financing with a U.S.-based investment fund. The proceeds will be utilized to expand its domestic markets, increase sales and to acquire additional drugs for its Beijing retail stores.
View the StockGuru Profile for Lotus Pharmaceuticals:
http://www.stockguru.com/profiles/ltus/
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $10,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site aresuitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
